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Abstract
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end of article.

Objective Time-dependent covariates are generally
available as longitudinal data were collected periodically
in the cohort study. To examine whether time-dependent
triglyceride to high-density lipoprotein cholesterol (TG/
HDL-C) ratio could predict the future risk of type 2 diabetes
mellitus (T2DM) and assess its potential impact on the risk
of T2DM incidence.
Research design and methods This study enrolled 1460
participants without T2DM aged 55 or above in 1992 in
the Beijing Longitudinal Study of Aging during 25 years.
The questionnaire data were collected in nine surveys
from 1992 to 2017. Physical examination and blood
laboratory tests including TG and HDL-C concentrations
were measured in five surveys. Incident T2DM cases
were confirmed via a self-reported history of T2DM or the
fasting plasma glucose level.
Results 119 new cases of T2DM were identified. In the
Cox regression analysis with time-dependent TG/HDL-C
ratios and covariates, the adjusted hazard ratios (95%
confidence interval) of T2DM incidence were 1.90 (1.12
to 3.23), 2.75 (1.58 to 4.80) and 2.84 (1.69 to 4.77),
respectively, for those with TG/HDL-C ratios (both TG
and HDL-C were expressed in millimole per liter) in the
ranges of 0.87–1.30, 1.31–1.74 and ≥1.75, compared
with individuals with TG/HDL-C ratios <0.87. The similar
results of subdistribution hazard ratios were obtained by
performing the Fine-Gray model with time-dependent TG/
HDL-C ratios. This positive association and the statistically
significant trend with increased risk of T2DM incidence
in the three categories of elevated TG/HDL-C ratio was
confirmed by multiple sensitivity analyses. Furthermore,
the T2DM discriminatory power of TG/HDL-C ratio
combining with other risk factors was moderately high.
Conclusions We found that time-dependent TG/HDL-C
ratios were positively associated with the risk of T2DM
risk. The elevated TG/HDL-C ratios increased the future
risk of T2DM incidence. Lowering the TG/HDL-C ratio could
assist in the prevention of diabetes for older adults.
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Introduction
Type 2 diabetes mellitus (T2DM) imposes
a large economic burden on the global
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Significance of this study
What is already known about this subject?
►► A few studies have examined the association of tri-

glyceride to high-density lipoprotein cholesterol (TG/
HDL-C) ratio at baseline and the future risk of type 2
diabetes mellitus (T2DM).
►► Levels of TG and HDL-C commonly tend to fluctuate over time. However, few studies have evaluated
the association between the TG/HDL-C ratio and the
risk of T2DM by accounting for time-dependent TG/
HDL-C ratios.

What are the new findings?
►► Time-
dependent TG/HDL-
C ratios were positively

associated with the future risk of T2DM incidence
in the Beijing elderly population. Elevated TG/HDL-C
ratios significantly increased the risk of T2DM incidence. This positive association was confirmed by
multiple sensitivity analyses.
►► The association of TG/HDL-C ratios at baseline or
the average ratios during the follow-up period with
the future T2DM incidence was weaker or stronger,
respectively, than the one between time-dependent
TG/HDL-C ratios and T2DM incidence.
►► The T2DM discriminatory powers of prediction models combining TG/HDL-C ratio and other risk factors
were moderately high.

How might these results change the focus of
research or clinical practice?
►► Lowering TG/HDL-
C ratio could assist to prevent

T2DM in the general population, and monitoring lipid
profile deserves more attention in clinical practice.

healthcare system.1 The prevalence of T2DM
is steadily increasing everywhere, most markedly in the world’s middle-income countries.
China is experiencing the world’s largest
diabetes epidemic. The prevalence of T2DM
in Mainland China has risen from a low 0.67%
in 1980 to an astounding 10.9% in 2013.2 The
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high-density lipoprotein cholesterol
ratio and the risk of type 2 diabetes
mellitus among Chinese elderly: the
Beijing Longitudinal Study of Aging
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Research design and methods
Study population
The BLSA is a community-
based prospective cohort
study specifically designed to investigate the risk factors
for common non-
communicable diseases of Chinese
people aged 55 and older, which was started in 1992 and
2

was implemented by the Capital Medical University.25 To
select a representative sample whose geographic distribution, economic status, age and education were similar
to those of the Beijing population older than 55 years,
a three-stage stratification-random clustering sampling
method was conducted during cohort establishment. A
full description of the design and implementation of this
cohort study has been described previously.25 26 Briefly,
3257 community residents who were from the Xuanwu
District (urban), Daxing County (suburb, rural) and
Huairou County (extended suburb, mountain), aged
at least 55 years were invited to participate in 1992. A
total of 2101 participants completed the questionnaire
assessments and physical examination of the first survey
from July 1992 to August 1992. These participants were
followed up in 1994, 1997, 2000, 2004, 2007, 2009, 2012
and 2017. In five surveys (1992, 2000, 2009, 2012 and
2017), participants underwent physical examinations
and laboratory tests. The data used in this study were
from this cohort implemented during the period from
1992 to 2017.
This study excluded 244 participants with diabetes
(a self-reported history of T2DM or a fasting plasma
glucose (FPG) concentration ≥7.0 mmol/L) at baseline. We also excluded 395 individuals, who failed to
complete the laboratory tests or had missing data for TG
levels or HDL-C levels at baseline. We further excluded
two participants who died from type 1 diabetes and had
no history of T2DM. Therefore, 1460 participants with
complete data were considered in the final analyses.
This study was in accordance with the principles of the
Declaration of Helsinki. All participants provided their
written informed consent before taking part in this
survey.
Measurement and data collection
In nine surveys, a standard vis-à-vis questionnaire was
used to collect the data on demographics (age, sex, residence and education level), behavior lifestyles (smoking
status, alcohol consumption levels and physical activity)
and the self-reported history of diseases. Heights and
weights were measured, in light clothing, with the use of
standardized stadiometers and scales, respectively. Blood
pressure was measured on the right arm using a standard
mercury sphygmomanometer or an electronic sphygmomanometer with the subjects resting for at least 5 min in
a sitting position. The face-to-face interview and physical
examination were conducted by trained senior medical
students. All laboratory examinations, including total
cholesterol (TC), low-
density lipoprotein cholesterol
(LDL-C), HDL-C, TGs, FPG, were performed at the laboratory of Xuanwu Hospital, Capital Medical University
(Beijing, China). All laboratory tests were measured by
taking venous blood after at least 8 hours of fasting in the
morning. Data were entered into a central database by an
experienced researcher.
BMJ Open Diab Res Care 2020;8:e000811. doi:10.1136/bmjdrc-2019-000811
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International Diabetes Federation estimated the number
of Chinese people aged 20–79 years with diabetes to be at
114.4 million in 2017.3 Identifying modifiable risk factors
and reducing the prevalence of these factors is essential
for the prevention of T2DM.
Dyslipidemia such as elevated triglycerides (TGs) or
decreased high-density lipoprotein cholesterol (HDL-C)
is a common feature accompanying T2DM and pre-
diabetic states.4–7 There are several prospective studies
that have demonstrated elevated blood TG levels to
increase the risk of diabetes,8–10 impaired glucose tolerance11 and impaired fasting glucose.12 Some studies
have shown that HDL-C is inversely associated with the
incidence of T2DM.13–15 Insulin resistance (IR) is a key
risk factor for T2DM. The triglyceride to high-density
lipoprotein cholesterol (TG/HDL-
C) ratio has been
reported to be a surrogate marker of IR.16–18 This might
be a simple and reliable method to assess IR. However,
only few prospective studies have evaluated the association between the TG/HDL-C ratio at baseline and the
incidence of T2DM.
To our knowledge, there have been only a 15-
year
prospective study in an urban community population
and a rural cohort study that examined whether the
higher TG/HDL-C ratio at baseline is associated with the
increase risk of incident T2DM in Chinese people. It is
worth noting that the majority of published studies19–22
on this topic were based on a single measure of TG/
HDL-C ratio, failing to take into account the potential
effect of change in the ratios over time. Many covariate
data such as TG, HDL-C and blood pressure are collected
regularly in longitudinal studies. They may fluctuate over
time and are commonly addressed as time-dependent (or
time-varying) covariates in statistics.23 24 Not accounting
for time-dependent and cumulative average of the TG/
HDL-C ratio over time could bias the true association
between the TG/HDL-C ratio and the risk of T2DM.
Thus, prospective studies that evaluate the unbiased
effect of the time-dependent TG/HDL-C ratio on the risk
of T2DM in the presence of time-varying confounders
are essential.
We took the opportunity of a well-designed prospective study of Beijing Longitudinal Study of Aging (BLSA)
with 25 years of follow-
up to investigate the association between time-
dependent TG/HDL-
C ratios and
the risk of T2DM incidence based on the longitudinal
data. Furthermore, we also examined whether a single
measure of TG/HDL-C ratio at baseline or average TG/
HDL-C ratio during the follow-up period was associated
with the future risk of T2DM incidence.

Epidemiology/Health Services Research

Assessment of confounding covariates
In the present study, considering the degree of economic
and educational level in Daxing County and Huairou
County to be more or less equal, these two counties were
combined into one group (ie, rural or non-urban sites).
Body mass index (BMI) was calculated as the weight in
kilograms divided by the height in meter square. Educational level was classified into the two groups: primary or
lower level and secondary level or higher level. Alcohol
use was defined as an average intake of alcohol of at least
50 mL per day. Physical activity level was classified into
the three groups of low, moderate and high with exercise
time of <3, 3–10 and >10 hours per week, respectively.
Assessments of incident T2DM
Incidence of T2DM was defined as a self-
reported
physician-diagnosed history of T2DM or a FPG concentration ≥7.0 mmol/L (126 mg/dL).30 31 All participants
were followed up for mortality from the baseline examination (July 1992) to the end of follow-up (December
2017). Dates of death were obtained from the death
certificates, hospital records, local police registry and the
interview with family members. The follow-up time was
accrued from the baseline to the date of T2DM, or the
baseline to the date of death, loss of follow-up, whichever
occurred first.
Statistical analysis
Continuous variables were expressed as means±SD.
Frequencies and percentages were used to express the
categorical variables. Cox regression with time-dependent
covariates was performed to estimate the association
between TG/HDL-C ratio and the risk of T2DM incidence. In the Cox regression, the last observation time
of the lost follow-up participant or the death time was
identified as the right-censored lifetime. To consider the
potential impact of death as competing risk events rather
than the right-censored, Fine-Gray’s proportional subdistribution hazards model was used to assess the association of TG/HDL-C with the risk of T2DM. Hazard ratio
(HR) and subdistribution hazard ratio (SHR) with corresponding 95% confidence interval (CI) were calculated
from Cox regression and Fine-Gray model, respectively.
Four-step forward multivariable-adjusted models were
built for the statistical analyses. Model 1 was adjusted for
age, sex, district, educational level, cigarette consumption, drinking status and physical activity level. Model 2
was adjusted for variables in model 1, as well as for BMI,
systolic blood pressure (SBP) and diastolic blood pressure
BMJ Open Diab Res Care 2020;8:e000811. doi:10.1136/bmjdrc-2019-000811

(DBP). Model 3 was adjusted for variables in model 2
plus TC and LDL-C. To examine whether the potential
association between TG/HDL-
C ratio and the risk of
T2DM was due to the single measure of FPG at baseline,
we further adjusted for FPG at baseline in model 4.
While for the analysis of time-dependent TG/HDL-C
ratio, age, cigarette consumption, drinking status, physical activity, BMI, SBP, DBP, TC and LDL-C were updated
during 1992–2012 as time-dependent confounders, and
sex, educational level, residence and FPG at baseline
were time-invariant variables. Longitudinal data of time-
dependent TG levels and HDL-C levels collected during
the follow-up time was used in the time-dependent Cox
regression and time-
dependent Fine-
Gray model. Cox
regression and Fine-Gray model with time-invariant TG/
HDL-C ratio and all confounding covariates measured
at baseline or the average levels of continuous variables
during the follow-
up period were also implemented
to explore its association with the risk of T2DM. The
linear trend test across TG/HDL-C ratio categories was
performed by assigning the median value to each category and modeling this as a continuous variable in separate regression models.
Multiple sensitivity analyses were performed to examine
whether the potential association between TG/HDL-C
ratio and the risk of T2DM was consistent. The restricted
cubic spline was used to assess the dose–response relationship between the average TG/HDL-C ratio and the risk
of T2DM. Finally, risk prediction models including TG/
HDL-C and other risk factors were built for predicting
the future T2DM incidence. The performance of these
risk prediction models was evaluated by plotting the time-
dependent Receiver Operating Characteristic (ROC)
curves and calculating the areas under curves (AUCs).
For all analyses, a two-tailed p-value <0.05 was considered to be statistically significant. All statistical analyses
were performed using R version 3.5.1 (R Foundation for
Statistical Computing, Vienna, Austria) and SAS V.9.4
(SAS Institute, Cary, North Carolina, USA).
Results
Among 1460 participants (733 men and 727 women)
at baseline, the mean age of the study population
was 68.82±8.50 years. Among these participants, the
mean±SD, median, the 25th and 75th quartiles (IQR) of
the follow-up duration were 9.68±6.76 years, 8.00 years,
4.34 years and 13.52 years (9.18 years), respectively.
During 14 133.21 person-years of follow-up, 119 new incident cases of T2DM were identified, 709 subjects died
and 567 individuals lost to the follow-up. The cumulative
newly onset incidence of T2DM was 8.42 per 1000 person-
years overall. The flowchart of this study and the incident
cases of T2DM in each survey is shown in figure 1. Table 1
summarizes the characteristics of the subjects according
to different surveys. During the follow-up, there were
an increase in the proportion of physical activity and a
reduction in smoking and alcohol intake.
3
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Assessments of TG/HDL-C ratio
The TG/HDL-C ratio was calculated as TG (millimole per
liter) divided by HDL-C (millimole per liter). Based on
previously published cut-points of TG/HDL-C ratio,27–29
the TG/HDL-C ratio was classified into four groups by
the values of 0.87, 1.31, 1.75 which were in accordance
with the values of 2.00, 3.00 and 4.00 when both TG and
HDL-C were expressed in milligram per deciliter.

Epidemiology/Health Services Research

The time-
dependent TG/HDL-
C ratios were positively and strongly associated with the future T2DM risk
(table 2). After step-forward adjustment for confounding
covariates, graded positive risk of T2DM incidence for
those with step-elevated TG/HDL-C ratios was similar
across four multivariable-adjusted models. In the analyses of the final model adjusted simultaneously for all
potential confounding factors, the HRs (95% CI) of
newly onset T2DM for those with TG/HDL-C ratios when
both TG and HDL-C were expressed in mmol/L (mg/
dL) in the ranges of 0.87–1.30 (2.00–2.99), 1.31–1.74
(3.00–3.99) and ≥1.75 (4.00) were 1.90 (1.12 to 3.23),
2.75 (1.58 to 4.80) and 2.84 (1.69 to 4.77), respectively,
compared with individuals with TG/HDL-C ratios <0.87
(2.00) (table 2). There were statistically significant trends
with increased risks of T2DM incidence in the three categories of elevated TG/HDL-C ratios (p-values<0.001 for
trend for all comparisons). In the competing risks regression analysis with the time-
dependent covariates, the
similar results of SHRs were obtained (table 2).
The association of TG/HDL-C ratios at baseline with
the future T2DM incidence was weaker than the one
for the association between time-dependent TG-HDL-C
ratios and T2DM incidence. The HRs of T2DM incidence for participants with baseline TG/HDL-C ratios
in the ranges of 0.87–1.30, 1.31–1.74 and ≥1.75 at baseline were 1.44 (0.84–2.48), 2.40 (1.39–4.17) and 2.53
(1.51–4.24) compared with individuals with TG/HDL-C
ratios <0.87, which were significantly less than those for
4

time-dependent TG/HDL-C ratio groups (tables 2 and
3). Furthermore, the group with TG/HDL-C ratios in the
range of 0.87–1.30 was not significantly associated with
the higher risk of T2DM (p-value=0.183) as compared
with the group with TG/HDL-
C ratio less than 0.87.
The similar results of smaller SHRs of T2DM incidence
for baseline TG/HDL-
C ratio than time-
dependent
TG/HDL-C were observed. Whereas, the association of
average TG/HDL-C ratios, based on the average level of
continuous covariates such as age, BMI, SBP, DBP, TC
and LDL-C during the follow-up period, with the T2DM
risk was stronger than the one for the association between
time-dependent TG-HDL-C ratios and T2DM incidence,
in which the HRs of T2DM incidence for participants
with average TG/HDL-C ratios in the ranges of 0.87–
1.30, 1.31–1.74 and ≥1.75 were 2.11 (1.22–3.65), 3.19
(1.77–5.76) and 3.46 (2.03–5.88) compared with individuals with TG/HDL-C ratios <0.87 in the Cox regression
analysis (tables 2 and 3), respectively.
Moreover, the time-
dependent TG/HDL-
C ratios
remained significantly associated with T2DM risk after
restricting 1049 participants with the age less than 75
years at baseline (figure 2A). In addition, we applied
the Cox regression and Fine-Gray model only using the
longitudinal data from 1992 to 2000, and we got the
similar significantly positive association between TG/
HDL-C ratios and the risk of T2DM (online supplementary table S1). Equally important, we compared the association between TG/HDL-C ratios and T2DM incidence
BMJ Open Diab Res Care 2020;8:e000811. doi:10.1136/bmjdrc-2019-000811
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Figure 1 Flowchart of the study population and the incidence of T2DM during the 25-year follow-up time of nine surveys.
(A) Flowchart of the participants included in the current study. (B) Flowchart of the participants developed to T2DM from
1992 to 2017. FPG, fasting plasma glucose; HDL-C, high-density lipoprotein cholesterol; T2DM, type2 diabetes mellitus; TG,
triglyceride.
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Variables
Age (years)
Male, n (%)

1992
(N=1460)
68.82 (8.50)
733 (50.21)

2000
(N=664)
73.62 (7.17)
317 (47.74)

2009
(N=232)
79.49 (5.04)
99 (42.67)

2012
(N=122)
82.10 (4.48)
51 (41.80)

2017
(N=65)
85.51 (3.66)
30 (46.15)

Educational level, n (%)
 Secondary or higher

300 (20.55)

148 (22.29)

54 (23.28)

32 (26.23)

23 (35.38)

1160 (79.45)

516 (77.71)

178 (76.72)

90 (73.77)

42 (64.62)

 Urban

828 (56.71)

338 (50.90)

94 (40.52)

52 (42.62)

33 (50.77)

 Rural

632 (43.29)

326 (49.10)

138 (59.48)

70 (57.38)

32 (49.23)

1008 (69.04)

515 (77.56)

200 (86.21)

106 (86.89)

57 (87.69)

 1–5

105 (7.19)

46 (6.93)

9 (3.88)

3 (2.46)

2 (3.08)

 >5

347 (23.77)

103 (15.51)

23 (9.91)

13 (10.66)

6 (9.23)

 Primary or lower
Residence, n (%)

Smoke, n (%)
 0

Alcohol intake, n (%)
 Yes

186 (12.74)

68 (10.24)

16 (6.90)

8 (6.56)

6 (9.23)

 No

1274 (87.26)

596 (89.76)

216 (93.10)

114 (93.44)

59 (90.77)

 <3

592 (40.55)

237 (35.69)

56 (24.14)

36 (29.51)

30 (46.15)

 3–10

604 (41.37)

256 (38.55)

96 (41.38)

51 (41.80)

20 (30.77)

 >10

264 (18.08)

171 (25.75)

80 (34.48)

35 (28.69)

15 (23.08)

22.98 (3.94)

22.61 (4.38)

22.63 (4.33)

Physical activity, hours/per week, n (%)

BMI (kg/m2)

23.13 (3.86)

23.76 (3.86)

SBP (mm Hg)

141.2 (25.2)

142.3 (25.0)

143.7 (21.8)

142.3 (22.1)

141.4 (24.3)

DBP (mm Hg)

81.5 (12.5)

80.0 (12.0)

76.7 (11.4)

75.6 (11.1)

72.3 (12.4)

FPG (mmol/L)

5.17 (0.98)

5.15 (0.94)

5.09 (0.91)

5.05 (0.96)

4.94 (1.06)

TC (mmol/L)

4.34 (1.02)

5.14 (1.15)

5.46 (1.18)

5.27 (1.16)

5.26 (1.18)

TG (mmol/L)

1.47 (0.75)

1.52 (0.97)

1.54 (0.95)

1.45 (0.80)

1.46 (0.75)

LDL-C (mmol/L)

2.99 (0.98)

2.93 (0.86)

2.92 (0.82)

2.93 (0.87)

2.90 (0.89)

HDL-C (mmol/L)
TG/HDL-C

1.51 (0.58)
1.13 (0.87)

1.65 (0.52)
1.09 (1.03)

1.46 (0.45)
1.20 (0.96)

1.49 (0.37)
1.07 (0.71)

1.47 (0.35)
1.10 (0.75)

BMI, body mass index; DBP, diastolic blood pressure; FPG, fasting plasma glucose; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-
density lipoprotein cholesterol; SBP, systolic blood pressure; TC, total cholesterol; TG, triglyceride.

using the data by 2000 (8-year duration), 2004 (12-year
duration), 2012 (20-year duration) with the one by 2017
(25-year duration), and consistent results were obtained
(online supplementary figure S1). All sensitivity analyses
presented the robust conclusion that high TG/HDL-C
ratio was an independent risk factor of T2DM.
Significant positive association between average TG/
HDL-C ratio and T2DM risk was observed by performing
a restricted cubic spline Cox regression (figure 2B). HRs
and 95% CI were calculated for continuous TG/HDL-C
ratios with respect to the reference value of 0.87 after
simultaneous adjustment for all potential confounding
factors. Based on the association between TG/HDL-C
ratio and risk of T2DM, we found that there were significant dose–response relationships between the risk of
T2DM incidence and the average TG/HDL-
C ratios
(p-value <0.001 for linearity of TG/HDL-C ratio in the
BMJ Open Diab Res Care 2020;8:e000811. doi:10.1136/bmjdrc-2019-000811

Cox regression analysis). The HRs of incident T2DM
were significantly higher in those with higher TG/HDL-C
ratios compared with the reference level of 0.87.
We also analyzed other risk factors associated with the
T2DM incidence. The multivariate Cox regression analysis showed that elevated FPG, high BMI and more cigarette consumption were each positively associated with
the risk of T2DM, while age was negatively associated
with the risk of T2DM (online supplementary table S2).
Notably, TG/HDL-C ratio was the strongest one among
these associated risk factors.
Furthermore, a univariate Cox regression with TG/
HDL-
C ratio and a multivariate prediction model
including TG/HDL-C ratio, age, BMI, cigarette consumption and FPG were built for predicting the future T2DM
incidence. The discriminatory power of the multivariate
model (full model) combining TG/HDL-
C ratio with
5
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Table 1 Characteristics of the study participants according to the survey time
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TG/HDL-C ratio (mmol/L/mmol/L)
<0.87
Cox regression
1.00
 Model 1

0.87–1.30

1.31–1.74

≥1.75

Ptrend

2.15 (1.27 to 3.64)

3.45 (2.01 to 5.92)

3.58 (2.17 to 5.90)

<0.001

 Model 2

1.00

1.98 (1.17 to 3.36)

2.88 (1.66 to 5.01)

2.92 (1.74 to 4.89)

<0.001

 Model 3

1.00

1.95 (1.15 to 3.32)

2.83 (1.62 to 4.94)

2.90 (1.73 to 4.87)

<0.001

 Model 4

1.00

1.90 (1.12 to 3.23)

2.75 (1.58 to 4.80)

2.84 (1.69 to 4.77)

<0.001

2.22 (1.32 to 3.75)

3.40 (1.98 to 5.83)

4.03 (2.44 to 6.64)

<0.001

Fine-Gray model
 Model 1

1.00

 Model 2

1.00

1.98 (1.17 to 3.36)

2.67 (1.53 to 4.64)

3.10 (1.85 to 5.20)

<0.001

 Model 3
 Model 4

1.00
1.00

2.04 (1.20 to 3.47)
1.98 (1.16 to 3.37)

2.76 (1.58 to 4.82)
2.67 (1.53 to 4.68)

3.09 (1.84 to 5.19)
3.02 (1.80 to 5.08)

<0.001
<0.001

Model 1: Adjusted for age, sex, district, educational level, smoking consumption, drinking status and physical activity level.
Model 2: Included variables in model 1 and further adjusted for body mass index, systolic blood pressure and diastolic blood pressure.
Model 3: Adjusted for factors in model 2 plus total cholesterol and low-density lipoprotein cholesterol.
Model 4: Model 3 plus fasting plasma glucose.
HDL-C, high-density lipoprotein cholesterol; TG, triglyceride.

other risk factors, where the risk score was calculated
by 0.178*TG/HDL-C ratio - 0.040*age + 0.098*BMI +
0.027*cigarette + 0.269*FPG, was moderately high with
AUCs 0.713 (95% CI 0.620 to 0.805) and 0.733 (95% CI
0.669 to 0.797), respectively, for 5-year and 10-year T2DM
incidence. In addition, based on the results of Fine-
Gray model analysis, a multivariate predication model
accounting for the competing risk of death was set up
with slightly higher AUCs 0.727 (95% CI 0.639 to 0.815)

and 0.760 (95% CI 0.703 to 0.817), respectively, for 5-year
and 10-
year T2DM incidence (online supplementary
figure S2).
Discussion
In this prospective community-based and 25-year longitudinal follow-up study, we observed that time-dependent
TG/HDL-C ratios were positively associated with the risk

Table 3 Association of TG/HDL-C ratio with type 2 diabetes mellitus in the regression analyses with time-invariant ratio and
covariates
TG/HDL-C ratio (mmol/L/mmol/L)
Baseline TG/HDL-C
 No of subjects
 No of DM cases
 Incidence/1000
 person-years
 

<0.87

0.87–1.30

1.31–1.74

≥1.75

688

359

197

216

28

27

28

36

14.18

16.62

4.34

7.61

Ptrend

HR/SHR (95% CI)

Cox regression

1.00

1.44 (0.84 to 2.48)

2.40 (1.39 to 4.17)

2.53 (1.51 to 4.24) <0.001

Fine-Gray model

1.00

1.57 (0.91 to 2.69)

2.47 (1.42 to 4.29)

2.76 (1.64 to 4.63) <0.001

Average of TG/HDL-C
No of subjects
No of DM cases
Incidence/1000
person-years
 
Cox regression
Fine-Gray model

699

359

186

216

24

30

24

41

13.18

18.89

3.61

8.57

HR/SHR (95% CI)
1.00
1.00

2.11 (1.22 to 3.65)
2.23 (1.28 to 3.86)

3.19 (1.77 to 5.76)
2.97 (1.65 to 5.37)

3.46 (2.03 to 5.88) <0.001
3.80 (2.23 to 6.49) <0.001

DM, diabetes mellitus; HDL-C, high-density lipoprotein cholesterol; SHR, subdistribution HR; TG, triglyceride.
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Table 2 Adjusted HRs and SHRs (95% CI) for incidence of type 2 diabetes mellitus by TG/HDL-C ratio groups in the
regression analyses with time-dependent TG/HDL-C ratio and covariates
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of T2DM incidence. All sensitivity analyses showed that
TG/HDL-C was an independent risk factor of T2DM.
Multivariate prediction models combining TG/HDL-C
ratio and other risk factors were built and they had
moderately high discriminatory powers.
Some previous studies have demonstrated that high
TG/HDL-C ratio was associated with an increased risk of
T2DM.19–22 In a prospective cohort study including 5314
participants of African-
American, Hispanic, white and
Chinese-American ethnicity, T2DM also developed to a
significantly greater degree in subjects within the highest
group of TG/HDL-C ratios with HR 1.82 (95% CI 1.38 to
2.39) compared with individuals within the lowest group
of TG/HDL-
C ratios during a mean follow-
up of 7.7
years.20 In Chinese people, only two cohort studies have
examined whether elevated TG/HDL-C ratios were associated with the increased risk of T2DM incidence.19 22 One
cohort study, which included only 687 urban-community
adults of Chinese, conducted two surveys during a
15-year follow-up and demonstrated that an increased
TG/HDL-C ratios enhanced the risk of T2DM with an
adjusted OR 1.341 (p-value=0.010).19 Another prospective study from the Rural Chinese Cohort Study with
two surveys during 6-
year follow-
up and included 11
946 adults of Chinese rural population also showed that
people in the highest TG/HDL-C ratio group had the
twice risk of developing T2DM incidence than those in
the lowest ratio group with an HR of 2.11 (95% CI 1.55
to 2.86).22 However, those two studies included either
only urban or rural participants, which were not a good
representative sample of Chinese people. Furthermore,
since there were only two surveys in these two studies, the
conclusions of the association were only based on a single
measure. Few studies considered the effect of repeated-
measurement of TG/HDL-C ratio and the possible role
of time-varying confounders; thus, that might have biased
the strength of the association between TG/HDL-C ratio
BMJ Open Diab Res Care 2020;8:e000811. doi:10.1136/bmjdrc-2019-000811

and the incidence of T2DM. In our study that included
both urban and rural adults of Chinese population, we
have investigated the association of time-
dependent
TG/HDL-C ratios with the risk of T2DM incidence by
adjusting for time-
varying confounders meanwhile,
which could reduce these deficiencies of the previous
studies. Consistent with those findings, we discovered a
higher T2DM risk with an increased TG/HDL-C ratio
in multiple analyses. Moreover, the notion of the bias
discrepancy supported by our observations that the HRs
of T2DM risk for time-dependent TG/HDL-C ratios were
significantly larger than those for baseline TG/HDL-C
ratio in the current analysis. To the best of our knowledge, this is the only multicommunity prospective study
of Chinese population that used the TG/HDL-C ratio
as a time-dependent variable to examine the potential
impacts on T2DM risk.
Some previous reports provided some clues for understanding the mechanisms underlying this association of
TG/HDL-C ratios and the risk of T2DM incidence. First,
high plasma TG level can increase the IR of peripheral
tissues. The intrinsic IR can attenuate the effect of insulin
in suppressing TG lipolysis to glycerol and fatty acid, thus
high level of TGs leads to the release of more free fatty
acids.32 The latter can further exacerbate the problem
of insulin sensitivity, a vicious cycle between elevated TG
levels and IR,33 which may cause a further reduction in
glucose uptake and utilization by the peripheral tissues.34
Second, oxidation and inflammation can predict IR.
As HDL-
C has the ability of antioxidation and anti-
inflammation, reduction in HDL-C may further lead to
IR. Third, the combination of TG and HDL-C may have
stronger predictability for IR and diabetes. Many studies
have showed that the TG/HDL-
C may be a proxy of
IR to identify subjects at high risk of T2DM16 35 36 and
suggested that the TG/HDL-
C ratio may be a better
surrogate marker of IR than single indicators such as
7
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Figure 2 Association between TG/HDL-C ratios and the risk of T2DM incidence. (A) Adjusted HRs and sub-HRs (F-G model)
of T2DM incidence for different groups compared with the lowest group according to the time-dependent TG/HDL-C ratios
in the regression analyses among the participants aged less than 75 years in 1992. (B). Adjusted dose–response relationship
between the average TG/HDL-C ratios and the risk of T2DM using a restricted cubic spline curve with 95% CIs for HRs. F-G,
Fine-Gray; HDL-C, high-density lipoprotein cholesterol; T2DM, type2 diabetes mellitus; TG, triglyceride.
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measured lipid profile values are vital to predict the
adverse health outcomes and deserve more attention in
clinical practice.
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